Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Other Non-Current Liabilities (2023 - 2024)

Contineum Therapeutics has reported Other Non-Current Liabilities over the past 2 years, most recently at $228000.0 for Q1 2024.

  • Quarterly results put Other Non-Current Liabilities at $228000.0 for Q1 2024, changed N/A from a year ago — trailing twelve months through Mar 2024 was $228000.0 (changed N/A YoY), and the annual figure for FY2023 was $110000.0, changed.
  • Other Non-Current Liabilities for Q1 2024 was $228000.0 at Contineum Therapeutics, up from $110000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for CTNM hit a ceiling of $228000.0 in Q1 2024 and a floor of $110000.0 in Q4 2023.